Biobab AiBIO - Crunchbase Company Profile & Funding

Q: Who invested in Biobab AiBIO?

Biobab AiBIO has 6 investors including Mirae Asset Capital And SL Investment.

Q: When was the last funding round for Biobab AiBIO?

Biobab AiBIO closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Biobab AiBIO raised to date?

Biobab AiBIO has raised obfuscated.

Overview

Biobab AiBIO

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Biobab AiBIO

CB Rank

119102

Biobab AiBIO is a biotechnology company that develops drugs utilize artificial intelligence.

Founded

obfuscation

Private

Series A

Incheon, Inch'on-jikhalsi, South Korea

11-50

baobabaibio.com

Artificial Intelligence (AI)

Biotechnology

Medical

Pharmaceutical

Funding Rounds

Series A

OBF

obfuscation

Details

Legal Name

Baobab AiBIO Co., Ltd.

Also Known As

바오밥에이바이오

Operating Status

Active

Company Type

For Profit

Phone Number

+82 032 212 9770

Contact Email

admin@baobabaibio.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Bio-space Voyager

A technology integrating quantum mechanics-based drug design, bio-sub spaces hyper connecting technologies, AI-based PK prediction, and Cryo-EM for protein structure-based drug discovery.

Cryo-EM Platform

Operates in Single Particle Analysis, Micro-ED, and Cryo-Tomography modes, supporting high-resolution structural determination for drug development.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Biobab AiBIO	6	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Biobab AiBIO	6	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Biobab AiBIO	6	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Biobab AiBIO	6	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Biobab AiBIO	6	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Biobab AiBIO	6	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Biobab AiBIO	6	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Biobab AiBIO	6	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Biobab AiBIO	6	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - Biobab AiBIO	6	obfuscated obfuscation	—	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Mirae Asset Capital	—	Series A - Biobab AiBIO	—
Mirae Asset Capital	—	Series A - Biobab AiBIO	—
Mirae Asset Capital	—	Series A - Biobab AiBIO	—
Mirae Asset Capital	—	Series A - Biobab AiBIO	—
Mirae Asset Capital	—	Series A - Biobab AiBIO	—